1-8 of 8
Henry J Henk, PhD
Close
Sort by
Journal Articles

Real World Analysis Of Duration Of TKI Treatment Among Patients With Chronic Myeloid Leukemia

Henry J Henk, PhD, Mabel Woloj, PhD, Mark Shapiro, MD, PhD, Jennifer Whiteley, EdD
Journal: Blood
Blood (2013) 122 (21): 5175.
https://doi.org/10.1182/blood.V122.21.5175.5175
Published: 2013
Journal Articles

Persistence to Lenalidomide Improves Patient Outcomes While Remaining Cost-Neutral for the Treatment of Multiple Myeloma

Henry J Henk, PhD, Satyin Kaura, MEng, MBA, Zeba M. Khan, PhD, April Teitelbaum
Journal: Blood
Blood (2012) 120 (21): 4688.
https://doi.org/10.1182/blood.V120.21.4688.4688
Published: 2012
Journal Articles

Treatment Persistence with Azacitdine (Vidaza) Is Associated with Lower Inpatient Hospitalization Costs Over Time

B. Douglas Smith, M.D., Dalia Mahmoud, MBA, Stacey Dacosta Byfield, Henry J Henk, PhD
Journal: Blood
Blood (2012) 120 (21): 4231.
https://doi.org/10.1182/blood.V120.21.4231.4231
Published: 2012
Journal Articles

Effect of Age on Neutropenia-Related Hospitalization in Non-Hodgkin's Lymphoma Patients Receiving Myelosuppressive Chemotherapy

Henry J Henk, PhD, Robert G Deeter, PharmD, James A. Kaye, MD, DrPH, Laura K Becker, MS, Jason C Legg, PhD, Kenneth J Rothman, DrPH
Journal: Blood
Blood (2011) 118 (21): 2082.
https://doi.org/10.1182/blood.V118.21.2082.2082
Published: 2011
Journal Articles

An Evaluation of Health Care Utilization, Risk of Infection and Bleeding Among MDS Patients During Periods of Transfusion Dependence or Independence with or without Lenalidomide Therapy

B. Douglas Smith, MD, Dalia Mahmoud, Henry J Henk, PhD, Zeba M. Khan, PhD
Journal: Blood
Blood (2011) 118 (21): 3151.
https://doi.org/10.1182/blood.V118.21.3151.3151
Published: 2011
Journal Articles

Pegfilgrastim Use Associated with Lower Risk of Hospitalization Than Filgrastim Use: A Retrospective US Claims Analysis.

Arash Naeim, MD, Henry J Henk, PhD, Laura Becker, MS, Victoria Chia, PhD, Sejal Badre, MS, Robert G Deeter, PharmD
Journal: Blood
Blood (2010) 116 (21): 3801.
https://doi.org/10.1182/blood.V116.21.3801.3801
Published: 2010
Journal Articles

Retrospective Database Analysis of the Effect of Zoledronic Acid (ZOL) On Skeletal-Related Events (SREs) in Patients (Patients) with Multiple Myeloma (MM).

Henry J Henk, PhD, Satyin Kaura, Jose Ricardo Perez, Laura Becker
Journal: Blood
Blood (2009) 114 (22): 3881.
https://doi.org/10.1182/blood.V114.22.3881.3881
Published: 2009
Journal Articles

Retrospective Database Analysis of Patterns of Zoledronic Acid (ZOL) Treatment in Patients with Multiple Myeloma (MM) and Malignant Bone Lesions (BM).

Donna Spencer, Satyin Kaura, Jose Ricardo Perez, Henry J Henk, PhD
Journal: Blood
Blood (2009) 114 (22): 4944.
https://doi.org/10.1182/blood.V114.22.4944.4944
Published: 2009